TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.

Ryan B Corcoran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.